Baccharis dracunculifolia (Asteraceae) essential oil displays anti-inflammatory activity in models of skin inflammation

• Published in: Journal of ethnopharmacology Vol. 259; p. 112840
• Main Authors: Brandenburg, Margareth Mello, Rocha, Fernanda Grillo, Pawloski, Priscila Lúcia, Soley, Bruna da Silva, Rockenbach, Andressa, Scharf, Dilamara Riva, Heiden, Gustavo, Ascari, Jociani, Cabrini, Daniela Almeida, Otuki, Michel Fleith
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 15.09.2020
• Subjects: Animals; Anti-Inflammatory Agents - chemistry; Anti-Inflammatory Agents - pharmacology; Baccharis - chemistry; Baccharis dracunculifolia; Drug Eruptions - drug therapy; Drug Eruptions - pathology; Edema - chemically induced; Edema - drug therapy; Epidermis - pathology; Essential oil; Female; Inflammation; Lymphatic System - drug effects; Mice; Oils, Volatile - chemistry; Oils, Volatile - pharmacology; Plant Extracts - pharmacology; Plant Leaves - chemistry; Receptors, Glucocorticoid - metabolism; Skin; Inflammation; Skin; Essential oil; Baccharis dracunculifolia
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2020.112840

Baccharis dracunculifolia (Asteraceae) is a commonly used plant in traditional medicine known as “alecrim-do-campo”. Popularly it has been used as an immunostimulant, antibiotic, anti-inflammatory among other applications. So far, only a few studies have investigated the B. dracunculifolia anti-inflammatory effect and none has investigated the effectiveness of essential oil on skin diseases. The study aimed at evaluating the topical anti-inflammatory activity of B. dracunculifolia essential oil (BdEO) in mice models of acute and chronic skin inflammation. BdEO was obtained from leaves and it was analyzed with Gas Chromatograph. Topical anti-inflammatory activity of BdEO (0.1, 0.3 and 1.0 mg/ear) was evaluated in Arachidonic Acid or TPA-induced acute and chronic skin inflammation in mice. Parameters such edema, cell migration and keratinocytes proliferation were evaluated. In addition, safety and a possible mechanism of action for BdEO essential oil were also investigated. Our results indicate that mainly terpenoids compounds compose BdEO. In addition, topical treatment with BdEO inhibited inflammatory parameters in both acute and chronic models of skin inflammation. This protective effect was associated with reduced edema formation, smaller cellular influx into the inflamed tissue and reduction of keratinocytes hyperproliferation. Although BdEO appears to exert its anti-inflammatory effect through a corticosteroid pathway, no local or systemic side effects were observed. Taken together, the present results showed that the essential oil obtained by hydrodistillation from B. dracunculifolia leaf samples exhibit remarkable topical anti-inflammatory properties. Therefore, our study demonstrated evidence for BdEO topical anti-inflammatory efficacy and safety, suggesting that it could be considered for developing of a new phytotherapeutic formulation as treatment for skin diseases. [Display omitted]